Salveen Richter
Stock Analyst at Goldman Sachs
(4.62)
# 910
Out of 4,983 analysts
547
Total ratings
50.1%
Success rate
12.1%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Hold | $56 | $44.84 | +24.89% | 20 | Sep 14, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $41 | $17.30 | +136.99% | 7 | Sep 13, 2026 | |
| AMGN Amgen | Reiterated: Buy | $450 | $376.35 | +19.57% | 22 | Sep 8, 2026 | |
| BRVE Braveheart Bio | Reiterated: Buy | $48 | $27.45 | +74.86% | 2 | Sep 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $28 → $19 | $12.88 | +47.52% | 15 | Sep 4, 2026 | |
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $50 | $38.53 | +29.77% | 1 | Sep 2, 2026 | |
| LTGO Latigo Biotherapeutics | Reiterated: Buy | $73 | $23.06 | +216.57% | 1 | Sep 1, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | $69 → $70 | $64.73 | +8.14% | 18 | Aug 31, 2026 | |
| MRNA Moderna | Rated: Hold | $67 → $120 | $145.62 | -17.59% | 48 | Aug 19, 2026 | |
| TSHA Taysha Gene Therapies | Reiterated: Buy | $13 | $5.07 | +156.41% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $48 → $55 | $52.21 | +5.34% | 17 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.93 | +78.12% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 | $11.49 | -21.67% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $20 | $17.02 | +17.51% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $80 | $49.12 | +62.87% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $62 | $41.39 | +49.79% | 4 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $652 → $653 | $513.26 | +27.23% | 29 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $130 | $147.68 | -11.97% | 16 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $965 → $972 | $774.61 | +25.48% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $118 | $124.75 | -5.41% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $42.49 | +8.26% | 23 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $32.95 | -2.88% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $13.76 | +139.83% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $31 | $18.84 | +64.54% | 12 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $216.01 | +15.74% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $550 | $239.36 | +129.78% | 22 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $23.16 | +77.03% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $23.46 | +49.19% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $26 | $15.68 | +65.82% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $19.76 | -13.97% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $24.65 | -35.09% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $17 | $27.54 | n/a | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $10.80 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $40 | $20.06 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.11 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $3.48 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $30 | $17.28 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $5 | $27.67 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $68.30 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.60 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $58.47 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $2.71 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $31 | $1.69 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 | $220.31 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.00 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $10.78 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $1 | $6.63 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $9 | $3.19 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $34 → $6 | $2.92 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $4.76 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $131 | $529.09 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 | $1.38 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $4.22 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $47 | $65.79 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $2 | $8.72 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $498.48 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.46 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | Dec 2, 2011 |
Ionis Pharmaceuticals
Sep 14, 2026
Reiterated: Hold
Price Target: $56
Current: $44.84
Upside: +24.89%
Summit Therapeutics
Sep 13, 2026
Reiterated: Buy
Price Target: $41
Current: $17.30
Upside: +136.99%
Amgen
Sep 8, 2026
Reiterated: Buy
Price Target: $450
Current: $376.35
Upside: +19.57%
Braveheart Bio
Sep 8, 2026
Reiterated: Buy
Price Target: $48
Current: $27.45
Upside: +74.86%
Ultragenyx Pharmaceutical
Sep 4, 2026
Reiterated: Hold
Price Target: $28 → $19
Current: $12.88
Upside: +47.52%
Teva Pharmaceutical Industries
Sep 2, 2026
Reiterated: Buy
Price Target: $50
Current: $38.53
Upside: +29.77%
Latigo Biotherapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: $73
Current: $23.06
Upside: +216.57%
BioMarin Pharmaceutical
Aug 31, 2026
Reiterated: Hold
Price Target: $69 → $70
Current: $64.73
Upside: +8.14%
Moderna
Aug 19, 2026
Rated: Hold
Price Target: $67 → $120
Current: $145.62
Upside: -17.59%
Taysha Gene Therapies
Aug 11, 2026
Reiterated: Buy
Price Target: $13
Current: $5.07
Upside: +156.41%
Aug 10, 2026
Rated: Hold
Price Target: $48 → $55
Current: $52.21
Upside: +5.34%
Aug 6, 2026
Reiterated: Hold
Price Target: $7
Current: $3.93
Upside: +78.12%
Aug 6, 2026
Reiterated: Sell
Price Target: $9
Current: $11.49
Upside: -21.67%
Aug 6, 2026
Reiterated: Hold
Price Target: $16 → $20
Current: $17.02
Upside: +17.51%
Aug 5, 2026
Rated: Buy
Price Target: $67 → $80
Current: $49.12
Upside: +62.87%
Aug 5, 2026
Reiterated: Buy
Price Target: $58 → $62
Current: $41.39
Upside: +49.79%
Aug 4, 2026
Rated: Buy
Price Target: $652 → $653
Current: $513.26
Upside: +27.23%
Aug 3, 2026
Reiterated: Hold
Price Target: $130
Current: $147.68
Upside: -11.97%
Jul 30, 2026
Reiterated: Buy
Price Target: $965 → $972
Current: $774.61
Upside: +25.48%
Jul 29, 2026
Reiterated: Hold
Price Target: $110 → $118
Current: $124.75
Upside: -5.41%
Jul 29, 2026
Reiterated: Hold
Price Target: $46
Current: $42.49
Upside: +8.26%
Jul 21, 2026
Reiterated: Hold
Price Target: $32
Current: $32.95
Upside: -2.88%
Jul 20, 2026
Reiterated: Buy
Price Target: $33
Current: $13.76
Upside: +139.83%
Jul 20, 2026
Reiterated: Buy
Price Target: $22 → $31
Current: $18.84
Upside: +64.54%
Jul 13, 2026
Reiterated: Buy
Price Target: $250
Current: $216.01
Upside: +15.74%
Jun 25, 2026
Reiterated: Buy
Price Target: $550
Current: $239.36
Upside: +129.78%
Jun 1, 2026
Reiterated: Buy
Price Target: $41
Current: $23.16
Upside: +77.03%
May 13, 2026
Reiterated: Buy
Price Target: $35
Current: $23.46
Upside: +49.19%
Apr 9, 2026
Reiterated: Buy
Price Target: $14 → $26
Current: $15.68
Upside: +65.82%
Feb 25, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $19.76
Upside: -13.97%
Oct 30, 2025
Reiterated: Hold
Price Target: $16
Current: $24.65
Upside: -35.09%
Aug 7, 2025
Reiterated: Sell
Price Target: $15 → $17
Current: $27.54
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $19
Current: $10.80
Upside: n/a
Jan 28, 2025
Reiterated: Buy
Price Target: $46 → $40
Current: $20.06
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $10.11
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $3.48
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $37 → $30
Current: $17.28
Upside: n/a
Feb 16, 2024
Reiterated: Hold
Price Target: $48 → $5
Current: $27.67
Upside: n/a
Jan 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $68.30
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $63.60
Upside: n/a
Jul 31, 2023
Reiterated: Buy
Price Target: $53
Current: $58.47
Upside: n/a
Jun 12, 2023
Reiterated: Sell
Price Target: $7
Current: $2.71
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $32 → $31
Current: $1.69
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $225
Current: $220.31
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.00
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $10.78
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $2 → $1
Current: $6.63
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $8 → $9
Current: $3.19
Upside: n/a
Nov 3, 2022
Reiterated: Hold
Price Target: $34 → $6
Current: $2.92
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $4.76
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $126 → $131
Current: $529.09
Upside: n/a
Nov 9, 2020
Reiterated: Sell
Price Target: $11
Current: $1.38
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $4.22
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $45 → $47
Current: $65.79
Upside: n/a
Nov 13, 2019
Reiterated: Sell
Price Target: $4 → $2
Current: $8.72
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $498.48
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $2.46
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a